Pretreatment with Antithrombotic Agents During Radiofrequency Catheter Ablation: A Randomized Comparison of Aspirin Versus Ticlopidine
- 1 November 1998
- journal article
- clinical trial
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 9 (11), 1144-1151
- https://doi.org/10.1111/j.1540-8167.1998.tb00085.x
Abstract
D-dimer is a product of fibrin degradation and can serve as a biochemical marker of thrombus formation and reactive fibrinolysis. According to our previous observations, and as reflected by elevated plasma D-dimer levels, lesions produced by radiofrequency (RF) ablation have a thrombogenic effect. Pretreatment with combined aspirin and ticlopidine mitigates this thrombogenicity; however, the effect of either agent alone remains unknown. In this study, 59 patients undergoing RF ablation were randomized to pretreatment with aspirin (group I; n = 30) or ticlopidine (group II; n = 29) for 3 days prior to RF ablation. D-dimer levels were measured by enzyme immunoassay before and after the electrophysiologic study (EPS), and both immediately and at 48 hours after RF ablation. Results also were compared with those of 31 patients (nonrandomized group III) who had received both aspirin and ticlopidine. At all stages, D-dimer levels were higher in groups I and II when compared with group III. Baseline D-dimer (31+/-20 vs 24+/-13 vs 17+/-11 microg/L, respectively; P = 0.002) rose after EPS to higher levels in groups I and II (91+/-100 microg/L and 51+/-35 microg/L) compared with group III (31+/-17 microg/L; P = 0.001). After RF ablation, D-dimer levels increased in all groups, but this increase was much higher in groups I and II (214+/-210 microg/L and 201+/-222 microg/L) than in group III (74+/-60 microg/L; P = 0.005). At 48 hours, D-dimer levels decreased in all groups, but remained higher in groups I and II (91+/-100 microg/L and 95+/-99 microg/L) than in group III (35+/-31 microg/L; P = 0.009). There were no differences among the three groups in the number of RF ablation lesions or the duration of the RF ablation procedure. Pretreatment with aspirin or ticlopidine alone does not decrease the thrombogenic potential of RF ablation. Only combined therapy with aspirin and ticlopidine has a favorable effect, as reflected by the lower degree of D-dimer elevation.Keywords
This publication has 20 references indexed in Scilit:
- Ablation of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 1997
- Thrombogenicity of radiofrequency lesions: Results with serial D-dimer determinationsJournal of the American College of Cardiology, 1996
- The Evolution of Platelet Aggregability in Patients Undergoing Catheter Ablation for Supraventricular Tachycardia with Radiofrequency Energy: The Role of Antiplatelet TherapyPacing and Clinical Electrophysiology, 1995
- NASPE Survey on Catheter AblationPacing and Clinical Electrophysiology, 1995
- Radiofrequency ablation of left-sided accessory pathways: Transaortic versus transseptal approachAmerican Heart Journal, 1994
- The Multicentre European Radiofrequency Survey (MERFS): Complications of radiofrequency catheter ablation of arrhythmiasEuropean Heart Journal, 1993
- Role of Radiofrequency Ablation in the Management of Supraventricular Arrhythmias:Journal of Cardiovascular Electrophysiology, 1993
- Catheter ablation of accessory atrioventricular pathways in young patients: Use of long vascular sheaths, the transseptal approach and a retrograde left posterior parallel approachJournal of the American College of Cardiology, 1993
- Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: Results in 100 consecutive patientsJournal of the American College of Cardiology, 1992
- Transesophageal Echocardiographic Evaluation for Mural Thrombus Following Radiofrequency Catheter Ablation of Accessory PathwaysPacing and Clinical Electrophysiology, 1991